Michael John Allen Bellecourt, USPTO Patent Examiner

Listed by the USPTO as BELLECOURT, MICHAEL JOHN ALLEN

Tech Center 1600 • Art Units: 1671

This examiner grants 0% of resolved cases

Performance Statistics

—

Allow Rate

-60.0% vs TC avg

Total Applications

—

Interview Lift

Avg Prosecution Days

Based on 0 resolved cases, 2023–2026

§101 Eligibility

18.2%

§102 Novelty

18.2%

§103 Obviousness

54.6%

§112 Clarity

App #	Title	Status	Assignee
18374118	INTRANASAL VACCINE COMPOSITION AND METHOD FOR BOOSTING USING THE SAME	Non-Final OA	ADVAGENE BIOPHARMA CO., LTD.
18506464	METHODS AND COMPOSITIONS FOR IDENTIFYING VIRAL SEQUENCES	Non-Final OA	DECODE CURE LIMITED
18286852	CAMELID ANTI-SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS ANTIBODIES	Non-Final OA	Jody BONNEVIER
18285729	BACTERIOPHAGE COMPOSITIONS FOR TREATING CLOSTRIDIUM PERFRINGENS INFECTIONS	Non-Final OA	APARON LTD.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Michael John Allen Bellecourt examines applications in Art Unit 1671 in Tech Center 1600 (Biotechnology & Pharmaceuticals).